Endoscopic Retrograde Cholangiopancreatography Patient Registry
Endoscopic Retrograde Cholangiopancreatography Patient Registry
The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.
The primary objective of this study is to provide a mechanism to store the following information about patients undergoing ERCPs at Methodist Dallas Medical Center. This registry will be permissive of quality improvement and research studies.
Inclusion Criteria:
Patients >15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025
Exclusion Criteria:
Patients <15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.
ClinicalResearch@mhd.com214-947-1280
ClinicalResearch@mhd.com214-947-4604